Observational studyBMC infectious diseases2025

Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data.

Valentina Iannone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.